OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001446159

Axe Compute Inc. (AGPU)

Axe Compute Inc. (CIK 0001446159, ticker AGPU, EIN 33-1007393) reported revenue of $125,284 for FY2025 (2025-01-01 to 2025-12-31) and net income of -$233.1 million (-$233,095,203) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-03-31 (accession 0001171843-26-002094).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001446159
TickersAGPU (Nasdaq)
EIN33-1007393
SIC industry code6199 Finance Services
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_2pf30kjwrb0cnc3ye8340h44ta
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$125,284FY20252025-01-01 to 2025-12-3110-K2026-03-310001171843-26-002094RevenueFromContractWithCustomerIncludingAssessedTax
Net income-$233,095,203FY20252025-01-01 to 2025-12-3110-K2026-03-310001171843-26-002094NetIncomeLoss
Total assets$52,888,346FY2025as of 2025-12-3110-K2026-03-310001171843-26-002094Assets
Total liabilities$5,171,391FY2025as of 2025-12-3110-K2026-03-310001171843-26-002094Liabilities
Stockholders' equity$47,716,955FY2025as of 2025-12-3110-K2026-03-310001171843-26-002094StockholdersEquity
Operating cash flow-$9,876,039FY20252025-01-01 to 2025-12-3110-K2026-03-310001171843-26-002094NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Diluted earnings per share$0.36 per shareFY20212021-01-01 to 2021-12-3110-K2022-03-310001171843-22-002237EarningsPerShareBasicAndDiluted
Shares outstanding5,539,267 sharesFY2025as of 2026-03-2710-K2026-03-310001171843-26-002094EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$125,28410-K2026-03-310001171843-26-002094
RevenueFY20242024-01-01 to 2024-12-31$84,81210-K2026-03-310001171843-26-002094
RevenueFY20232023-01-01 to 2023-12-31$1,627,69710-K2025-03-310001171843-25-001863
RevenueFY20222022-01-01 to 2022-12-31$1,505,45910-K2024-03-280001171843-24-001694
RevenueFY20212021-01-01 to 2021-12-31$1,420,68010-K2023-03-210001171843-23-001805
RevenueFY20202020-01-01 to 2020-12-31$1,252,27210-K2022-03-310001171843-22-002237
RevenueFY20192019-01-01 to 2019-12-31$1,411,56510-K2021-03-150001171843-21-001786
RevenueFY20182018-01-01 to 2018-12-31$1,411,65510-K2020-04-010001171843-20-002217
RevenueFY20172017-01-01 to 2017-12-31$654,83610-K/A2019-04-020001171843-19-002172
Net incomeFY20252025-01-01 to 2025-12-31-$233,095,20310-K2026-03-310001171843-26-002094
Net incomeFY20242024-01-01 to 2024-12-31-$12,664,38810-K2026-03-310001171843-26-002094
Net incomeFY20232023-01-01 to 2023-12-31-$13,983,96710-K2025-03-310001171843-25-001863
Net incomeFY20222022-01-01 to 2022-12-31-$25,737,63410-K2024-03-280001171843-24-001694
Net incomeFY20212021-01-01 to 2021-12-31-$19,657,17410-K2023-03-210001171843-23-001805
Net incomeFY20202020-01-01 to 2020-12-31-$25,884,39710-K2022-03-310001171843-22-002237
Net incomeFY20192019-01-01 to 2019-12-31-$19,390,76610-K2021-03-150001171843-21-001786
Net incomeFY20182018-01-01 to 2018-12-31-$10,086,47710-K2020-04-010001171843-20-002217
Net incomeFY20172017-01-01 to 2017-12-31-$6,003,01710-K/A2019-04-020001171843-19-002172
Net incomeFY20162016-01-01 to 2016-12-31-$6,526,01410-K2018-04-020001171843-18-002453
  • Revenue for FY2024 was restated: first reported as $1,623,817 (accession 0001171843-25-001863, filed 2025-03-31).
  • Revenue for FY2023 was restated: first reported as $1,780,093 (accession 0001171843-24-001694, filed 2024-03-28).
  • Net income for FY2017 was restated: first reported as -$7,746,593 (accession 0001171843-18-002453, filed 2018-04-02).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-142026-06-300001171843-26-005556agpu20260630_10q.htm
10-Q2026-05-152026-03-310001171843-26-003484agpu20260331_10q.htm
10-K2026-03-312025-12-310001171843-26-002094poai20251231_10k.htm
10-Q2025-11-142025-09-300001171843-25-007342poai20250930_10q.htm
10-Q2025-08-132025-06-300001171843-25-005375poai20250630_10q.htm
10-Q2025-05-142025-03-310001171843-25-003182poai20250331_10q.htm
10-K2025-03-312024-12-310001171843-25-001863poai20241231_10k.htm
10-Q2024-11-122024-09-300001171843-24-006292poai20240930_10q.htm
10-Q2024-08-132024-06-300001171843-24-004757poai20240630_10q.htm
10-Q2024-05-142024-03-310001171843-24-002875poai20240331_10q.htm
10-K2024-03-282023-12-310001171843-24-001694poai20231231_10k.htm
10-Q2023-11-132023-09-300001171843-23-007043poai20230930_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001446159published by the sourcedata.sec.gov/submissions/CIK0001446159.json2026-10-21
Employer Identification Number (EIN) · US-EIN33-1007393published by the sourcedata.sec.gov/submissions/CIK0001446159.json2026-10-21

Former names

NameFromTo
Predictive Oncology Inc.2019-06-132025-12-11
Precision Therapeutics Inc.2018-04-022019-06-04
Skyline Medical Inc.2013-08-082018-02-06
BioDrain Medical, Inc.2008-11-122013-08-07

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001446159.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001446159.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001446159" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001446159/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001446159/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1446159"}

On SEC EDGAR

About this data